January 16, 2018 / 10:10 PM / 6 months ago

Celgene in talks to buy Juno Therapeutics - WSJ

Jan 16 (Reuters) - Celgene Corp is in talks to buy Juno Therapeutics Inc, the Wall Street Journal reported, citing sources familiar with the matter. (on.wsj.com/2EMlysO)

Shares of Juno, which has a market value of $5.57 billion, were up 36 percent at $62.50 in extended trading on Tuesday.

The WSJ report comes days after Celgene said it had agreed to acquire Impact Biomedicines for as much as $7 billion, subject to certain milestones associated with regulatory hurdles and sales performance. (Reporting by Ankur Banerjee in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below